![Nederlof Michel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nederlof Michel
Plus aucun poste en cours
Historique de carrière de Nederlof Michel
Anciens postes connus de Nederlof Michel
Sociétés | Poste | Début | Fin |
---|---|---|---|
Cernostics, Inc.
![]() Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Directeur Technique/Scientifique/R&D | 16/06/2011 | - |
Fondateur | 15/06/2011 | - | |
President | 16/06/2011 | - |
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
President | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Cernostics, Inc.
![]() Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Health Technology |
- Bourse
- Insiders
- Nederlof Michel
- Expérience